- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 730.46K sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 612.72K sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 101.98K sh |
| Capex | Q1 2026 · Mar 31, 2026 | $71K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.42M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$809K |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $364K |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $740K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $4.3M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $3.83M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $12.97M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $16.01M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.74M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.43M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.54M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $4.68M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $8.22M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $6.01M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $16.4M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $20.41M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$10.74 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$85.25 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$10.74 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$18.00 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.9M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $503K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $275K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$6.58M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$1.19M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$8.23M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$503K |